$ABUS 4 SEC Filings

Filed On	Filing
07 Oct 2026	Form 4: Beardsley Robert A, Director Returned 17,948 shares to the issuer ($89.7K)
07 Oct 2026	Form 4: Nguyen Tuan, Chief Financial Officer Returned 48,081 shares to the issuer ($240K)
07 Oct 2026	Form 4: Sawhney Roger, Director Returned 17,142 shares to the issuer ($85.7K)
07 Oct 2026	Form 4: Androski Lindsay, Director Returned 24,655 shares to the issuer ($123K)
05 Oct 2026	Form 4: Roivant Sciences Ltd., Director Returned 8,967,383 shares to the issuer ($44.8M)
23 Sep 2026	Form 4: Androski Lindsay, Director Received 126,864 shares by exercise or conversion ($418K) · Gave up 82,527 shares to cover exercise price or tax ($418K)
23 Sep 2026	Form 4: Nguyen Tuan, Chief Financial Officer Received 293,100 shares by exercise or conversion ($1.05M) · Gave up 206,637 shares to cover exercise price or tax ($1.05M)
23 Sep 2026	Form 4: Sawhney Roger, Director Received 131,333 shares by exercise or conversion ($510K) · Gave up 100,508 shares to cover exercise price or tax ($510K)
23 Sep 2026	Form 4: Beardsley Robert A, Director Received 131,333 shares by exercise or conversion ($502K) · Gave up 99,057 shares to cover exercise price or tax ($502K)
10 Jun 2026	Form 4: Sawhney Roger, Director Granted 78,800 Stock Option (Right to Buy)
10 Jun 2026	Form 4: Beardsley Robert A, Director Granted 78,800 Stock Option (Right to Buy)
02 Feb 2026	Form 4: Nguyen Tuan, Chief Financial Officer Received 73,500 shares as a grant or award · Granted 188,400 Stock Option (Right to Buy)
02 Feb 2026	Form 4: Androski Lindsay, Director Received 28,000 shares as a grant or award · Granted 71,700 Stock Option (Right to Buy)
06 Aug 2025	Form 4: Sawhney Roger, Director Granted 157,600 Stock Option (Right to Buy)
31 Mar 2025	Form 4: Nguyen Tuan, Chief Financial Officer Granted 750,000 Stock Option (Right to Buy)
20 Mar 2025	Form 4: Hasija Anuj, Director Granted 157,600 Stock Option (Right to Buy)
20 Mar 2025	Form 4: Beardsley Robert A, Director Granted 157,600 Stock Option (Right to Buy)
20 Mar 2025	Form 4: Androski Lindsay, Director Granted 310,422 Stock Option (Right to Buy)
19 Feb 2025	Form 4: Naftzger J. Christopher, General Counsel and CCO Received 54,300 shares as a grant or award · Granted 220,300 Stock Option (Right to Buy)
19 Feb 2025	Form 4: McElhaugh Michael J., Director Received 177,000 shares as a grant or award · Granted 718,800 Stock Option (Right to Buy)

Comments